We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · June 09, 2020

Real-World Outcomes of mRCC Treatment

In Vivo (Athens, Greece)


Additional Info

In Vivo (Athens, Greece)
mRCC Outcome in the Treatment of Metastatic Renal Cell Carcinoma - A German Single-Center Real-World Experience
In Vivo 2018 Nov 01;32(6)1617-1622, M Schwab, R Hofmann, H Heers, A Hegele

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading